Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

26 to 50 of 190 results

Troubled Ranbaxy to be acquired by Sun Pharma for around $4 billion

Troubled Ranbaxy to be acquired by Sun Pharma for around $4 billion

07-04-2014

In something of a surprise announcement, Sun Pharmaceutical Industries revealed this morning that it…

Daiichi SankyoGenericsIndiaMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceuticals

Sweden’s Meda rejects Mylan’s takeover overture

Sweden’s Meda rejects Mylan’s takeover overture

06-04-2014

After a day of rumor and speculation about a takeover approach from US generic firm Mylan, Swedish drugmaker…

GenericsMedaMergers & AcquisitionsMylan Laboratories

Pamplona buys majority stake in US generic firm Alvogen

02-04-2014

Pamplona Capital Management has as acquired a majority stake in privately-held US company Alvogen, which…

AlvogenGenericsMergers & Acquisitions

Actavis forks out $100 million for Thai generics firm

Actavis forks out $100 million for Thai generics firm

02-04-2014

Ireland-headquartered US generic major Actavis has acquired Silom Medical Company, a privately held generic…

Asia-PacificAurobindo PharmaGenericsMergers & AcquisitionsSilom Medical CompanyTeva Pharmaceutical Industries

AMRI to acquire Cedarburg Pharmaceuticals in $41 million deal

24-03-2014

Albany Molecular Research, a USA-based contract research and manufacturing organization, has signed a…

Albany Molecular ResearchCedarburg PharmaFinancialGenericsMergers & Acquisitions

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Actavis confirms plan to acquire Forest Labs for about $25 billion

Actavis confirms plan to acquire Forest Labs for about $25 billion

18-02-2014

After a morning of speculation and rumors, generics drug major Actavis today confirmed that it has reached…

ActavisForest LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

US regulator calls for divestment for Endo Health’s acquisition of Boca Pharmacal to proceed

US regulator calls for divestment for Endo Health’s acquisition of Boca Pharmacal to proceed

02-02-2014

US specialty health care firm Endo Health Solutions and its takeover target generic drugmaker Boca Pharmacal…

Boca PharmacalEndo Health SolutionsGenericsMergers & AcquisitionsNorth AmericaRegulationUSA

Actavis to shed another business, its Actavis Foshan unit in China

Actavis to shed another business, its Actavis Foshan unit in China

26-01-2014

US generics major Actavis revealed a second divestiture this month, saying it has signed and completed…

ActavisAsia-PacificChinaGenericsMergers & AcquisitionsZhejiang Chiral

Par Pharmaceutical to acquire JHP Pharmaceutical

21-01-2014

US privately-held Par Pharmaceutical has entered into a definitive agreement to acquire JHP Group Holdings,…

GenericsJHP PharmaceuticalsMergers & AcquisitionsPar Pharmaceutical

Actavis to divest certain European operations to Aurobindo

Actavis to divest certain European operations to Aurobindo

18-01-2014

US generics major Actavis plans to enter into an agreement with India’s Aurobindo Pharma for the latter…

ActavisAurobindo PharmaEuropeGenericsMergers & Acquisitions

Alvogen takes 67% stake in Lotus Pharma

17-01-2014

Privately-owned US generics firm Alvogen revealed that, last month, it agreed to become the majority…

AlvogenAsia-PacificGenericsLotus PharmaceuticalsMergers & Acquisitions

Hepalink to acquire USA’s Scientific Protein Laboratories

27-12-2013

China’s Shenzhen Hepalink Pharmaceutical has entered into a stock purchase agreement to acquire USA-based…

GenericsheparinMergers & AcquisitionsScientific Protein LaboratoriesShenzhen Hepalink Pharmaceutical

ANI Pharma buys 31 generic drugs from Teva

ANI Pharma buys 31 generic drugs from Teva

27-12-2013

Emerging US generic drugmaker ANI Pharmaceuticals says that it has acquired 31 previously marketed generic…

ANI PharmaceuticalsGenericsMergers & AcquisitionsTeva Pharmaceutical Industries

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

12-12-2013

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

ActavisGenericsMergers & AcquisitionsNorth AmericaRegulationReproductiveWarner Chilcott

Actavis sells 51% stake in Russian subsidiary

Actavis sells 51% stake in Russian subsidiary

10-12-2013

Leading global generics drugmaker Actavis says that it sold its 51% stake in the Russian drug company…

ActavisEastern EuropeFarmekoGenericsMergers & AcquisitionsRussiaZio-Zdorovye

Polpharma manufacturing division assimilates Sanfarm in Nowa Dęba

30-11-2013

Sanfarm, a company operating in the Tarnobrzeg Economic Zone in Poland, has become part of leading Polish…

Eastern EuropeGenericsMergers & AcquisitionsPolpharmaProductionSanfarm

KKR acquires $200 million stake in India’s Gland Pharma

KKR acquires $200 million stake in India’s Gland Pharma

29-11-2013

Indian injectable generic firm Gland Pharma says it has reached an agreement under which Kohlberg Kravis…

Asia-PacificGenericsGland PharmaMergers & Acquisitions

DSM and JLL to create pharma services company in $2.6 billion transaction

20-11-2013

USA-based private equity firm JLL Partners and Dutch life and material science group Royal DSM have announced…

DSMGenericsMergers & Acquisitions

Akorn shells out $52.8 million for rights to three Merck drugs

Akorn shells out $52.8 million for rights to three Merck drugs

18-11-2013

USA-based niche generic drugmaker Akorn has acquired from pharma giant Merck & Co the US rights to three…

AkornAzaSiteCosoptGenericsMerck & CoMergers & AcquisitionsNorth AmericaOphthalmics

Abraaj sells stake in Opalia Pharma to Recordati

05-11-2013

The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Akorn buy of Hi-Tech Pharmacal delayed by FTC request

13-10-2013

In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

Actavis and Warner Chilcott to sell products to settle charges by FTC that their merger is 'uncompetitive'

28-09-2013

Actavis has agreed to sell all rights and assets to four generic pharmaceuticals to settle US Federal…

ActavisAmneal PharmaAtelviaFemcon FeGenericsLegalLoestrin 24 FeMergers & AcquisitionsWarner ChilcottWomen's Health

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

27-09-2013

The USA’s Federal Trade Commission will require Mylan and Agila Specialties to divest 11 generic injectable…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaStrides Arcolab

26 to 50 of 190 results

Back to top